Regulatory affairs

Bennett's Regulatory Affairs Department is one of the most important departments of the company, as it is in charge of maintaining and managing the regulatory and drug approval processes.

The areas which the Regulatory Affairs Department is concerned with, include the evaluation of new medicines and any new safety information, regulations in relation to side effects reporting, as well as manufacturing compliance with Good Clinical Practice, Good Manufacturing Practice, Good Distribution Practice and Good Pharmacovigilance Practice.


This Department is in constant cooperation and interaction with the National Organization for Medicines, the EMA, European regulatory authorities, as well as the national regulatory authorities of countries outside Europe with which Bennett develops partnerships.

en_USEnglish